sales@intentmarketresearch.com
+1 463-583-2713
As per Intent Market Research, the Agricultural Biotechnology Market was valued at USD 101.5 billion in 2023 and will surpass USD 185.5 billion by 2030; growing at a CAGR of 9.0% during 2024 - 2030.
The agricultural biotechnology market is at the forefront of modern agriculture, enabling innovations that enhance crop yield, resilience, and sustainability. With the global population projected to reach over nine billion by 2050, the demand for sustainable food production is more pressing than ever. Agricultural biotechnology encompasses a range of techniques, including genetic engineering, molecular diagnostics, and tissue culture, aimed at improving the quality and quantity of agricultural products. This market spans various applications, including vaccine development, transgenic crops and animals, and nutritional supplements, addressing the pressing challenges of food security, pest resistance, and environmental sustainability.
The advancements in biotechnology have revolutionized the agricultural landscape, providing farmers with tools to increase productivity while minimizing environmental impacts. By employing innovative methods, such as gene editing and molecular diagnostics, agricultural biotechnology is set to play a crucial role in ensuring sustainable agricultural practices. The market is characterized by a diverse range of segments, including organism types and applications, each contributing uniquely to the overall growth of the industry.
The genetic engineering segment of the agricultural biotechnology market is the largest, primarily due to its versatility and wide-ranging applications in agriculture. Genetic engineering techniques, such as gene modification (GM), gene editing (using CRISPR and TALEN), and RNA interference (RNAi), allow scientists to introduce specific traits into crops and livestock. This capability enables the development of crops that are resistant to pests, diseases, and environmental stresses, ultimately improving yield and reducing dependency on chemical pesticides.
The growing acceptance of genetically modified organisms (GMOs) among consumers and regulatory bodies has further bolstered the growth of the genetic engineering segment. Farmers are increasingly adopting GM crops for their improved resilience and productivity, which is crucial in the face of climate change and fluctuating market demands. As research and development continue to advance, the genetic engineering segment is expected to maintain its dominance, driving innovations that address global agricultural challenges effectively.
The molecular diagnostics segment of the agricultural biotechnology market is witnessing significant growth, driven by the increasing adoption of precision agriculture techniques. Molecular diagnostics, including marker-assisted selection (MAS) and genomic selection, enable farmers and researchers to identify genetic traits in crops and livestock more accurately. These tools facilitate informed decision-making in breeding programs, enhancing the efficiency and effectiveness of agricultural production.
As precision agriculture gains momentum, the demand for molecular diagnostic tools that can provide real-time data on plant and animal health is rising. The ability to quickly assess genetic traits and disease resistance is critical for developing resilient crop varieties and livestock. Moreover, the integration of molecular diagnostics with other agricultural technologies, such as data analytics and IoT, is expected to enhance their application and effectiveness further. This growing trend positions the molecular diagnostics segment as one of the fastest-growing sectors within the agricultural biotechnology market.
Among the crop types in the agricultural biotechnology market, oilseeds and pulses represent the fastest-growing segment, driven by rising nutritional demands and health-conscious consumer preferences. Oilseeds, such as soybeans and canola, are vital sources of protein and healthy fats, making them essential in diets worldwide. The demand for plant-based protein sources is growing, particularly in the context of vegetarian and vegan dietary trends, which boosts the interest in pulses as well.
Biotechnology plays a significant role in enhancing the nutritional profiles of oilseeds and pulses, leading to the development of varieties with improved yield and disease resistance. Furthermore, the rising global population and the need for sustainable agriculture practices underscore the importance of these crops. As consumers increasingly prioritize health and sustainability, the oilseeds and pulses crop type is poised for significant growth, making it a key focus area for agricultural biotechnology advancements.
The vaccine development application within the agricultural biotechnology market is experiencing rapid growth, fueled by increasing innovations in animal health. Vaccines play a critical role in preventing diseases in livestock, ensuring the health and productivity of animals, which is essential for maintaining food supply chains. With the rising focus on food safety and biosecurity, the demand for effective veterinary vaccines is growing, making this application one of the fastest-growing segments in the market.
The development of recombinant vaccines and novel delivery systems is enhancing the effectiveness and safety of animal vaccinations. As agricultural biotechnology continues to evolve, the integration of advanced technologies such as genomics and proteomics is expected to accelerate vaccine development processes. This growing emphasis on health innovations in livestock is likely to further propel the vaccine development application, positioning it as a vital component of the agricultural biotechnology market.
The North America region stands as the largest market for Agricultural Biotechnology, driven by a robust framework of research and development initiatives, particularly in the United States and Canada. This region is home to several leading agricultural biotech companies, research institutions, and universities that actively engage in developing innovative biotechnological solutions. The emphasis on genetically modified (GM) crops, including those resistant to pests and diseases, has significantly enhanced agricultural productivity and sustainability. Furthermore, regulatory frameworks in North America facilitate the commercialization of biotechnological products, thereby encouraging investments in agricultural biotech research and innovation.
The agricultural biotechnology market is characterized by a diverse and competitive landscape, featuring several leading companies that drive innovation and growth in the industry. Key players such as Arcadia Biosciences, Bayer AG, Certis USA L.L.C., Corteva, Eurofins Genomics LLC, Evogene Ltd., and KWS SAAT SE are at the forefront, offering a wide range of biotechnology solutions across various segments. These companies are engaged in continuous research and development, striving to introduce innovative products that address the evolving challenges in agriculture.
Strategic collaborations, mergers, and acquisitions are common in this dynamic market, enabling companies to enhance their technological capabilities and expand their market reach. Additionally, a focus on sustainability and environmentally friendly practices is driving competition among key players, as they seek to meet the growing consumer demand for sustainable agricultural solutions. The competitive landscape is marked by a commitment to innovation, with companies leveraging advanced technologies to improve agricultural productivity and sustainability in response to global food security challenges.
The report will help you answer some of the most critical questions in the Agricultural Biotechnology Market. A few of them are as follows:
Report Features |
Description |
Market Size (2023) |
USD 101.5 billion |
Forecasted Value (2030) |
USD 185.5 billion |
CAGR (2024 – 2030) |
9.0% |
Base Year for Estimation |
2023 |
Historic Year |
2022 |
Forecast Period |
2024 – 2030 |
Report Coverage |
Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments |
Segments Covered |
Agricultural Biotechnology Market By Organism Type (Genetic Engineering, Molecular Diagnostics, Tissue Culture) By Application (Vaccine Development, Transgenic Crops & Animals, Antibiotic Development, Nutritional Supplements) By Crop Type (Cereals & Grains, Oilseeds & Pulses, Fruits & Vegetables) |
Regional Analysis |
North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa) |
Customization Scope |
Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements |
1. Introduction |
1.1. Market Definition |
1.2. Scope of the Study |
1.3. Research Assumptions |
1.4. Study Limitations |
2. Research Methodology |
2.1. Research Approach |
2.1.1. Top-Down Method |
2.1.2. Bottom-Up Method |
2.1.3. Factor Impact Analysis |
2.2. Insights & Data Collection Process |
2.2.1. Secondary Research |
2.2.2. Primary Research |
2.3. Data Mining Process |
2.3.1. Data Analysis |
2.3.2. Data Validation and Revalidation |
2.3.3. Data Triangulation |
3.Executive Summary |
3.1. Major Markets & Segments |
3.2. Highest Growing Regions and Respective Countries |
3.3. Impact of Growth Drivers & Inhibitors |
3.4. Regulatory Overview by Country |
4. Agricultural Biotechnology Market, by Organism Type (Market Size & Forecast: USD Million, 2022 – 2030) |
4.1. Genetic Engineering |
4.1.1. Gene Modification |
4.1.2. Gene Editing |
4.1.3. RNA Interference |
4.2. Molecular Diagnostics |
4.2.1. Marker-Assisted Selection |
4.2.2. Genomic Selection |
4.3. Tissue Culture |
4.4. Others |
5. Agricultural Biotechnology Market, by Crop Type (Market Size & Forecast: USD Million, 2022 – 2030) |
5.1. Cereals & Grains |
5.2. Oilseeds & Pulses |
5.3. Fruits & Vegetables |
5.4. Others |
6. Agricultural Biotechnology Market, by Application (Market Size & Forecast: USD Million, 2022 – 2030) |
6.1. Vaccine Development |
6.2. Transgenic Crops & Animals |
6.3. Antibiotic Development |
6.4. Nutritional Supplements |
6.5. Others |
7. Regional Analysis (Market Size & Forecast: USD Million, 2022 – 2030) |
7.1. Regional Overview |
7.2. North America |
7.2.1. Regional Trends & Growth Drivers |
7.2.2. Barriers & Challenges |
7.2.3. Opportunities |
7.2.4. Factor Impact Analysis |
7.2.5. Technology Trends |
7.2.6. North America Agricultural Biotechnology Market, by Organism Type |
7.2.7. North America Agricultural Biotechnology Market, by Crop Type |
7.2.8. North America Agricultural Biotechnology Market, by Application |
7.2.9. By Country |
7.2.9.1. US |
7.2.9.1.1. US Agricultural Biotechnology Market, by Organism Type |
7.2.9.1.2. US Agricultural Biotechnology Market, by Crop Type |
7.2.9.1.3. US Agricultural Biotechnology Market, by Application |
7.2.9.2. Canada |
7.2.9.3. Mexico |
*Similar segmentation will be provided for each region and country |
7.3. Europe |
7.4. Asia-Pacific |
7.5. Latin America |
7.6. Middle East & Africa |
8. Competitive Landscape |
8.1. Overview of the Key Players |
8.2. Competitive Ecosystem |
8.2.1. Level of Fragmentation |
8.2.2. Market Consolidation |
8.2.3. Product Innovation |
8.3. Company Share Analysis |
8.4. Company Benchmarking Matrix |
8.4.1. Strategic Overview |
8.4.2. Product Innovations |
8.5. Start-up Ecosystem |
8.6. Strategic Competitive Insights/ Customer Imperatives |
8.7. ESG Matrix/ Sustainability Matrix |
8.8. Manufacturing Network |
8.8.1. Locations |
8.8.2. Supply Chain and Logistics |
8.8.3. Product Flexibility/Customization |
8.8.4. Digital Transformation and Connectivity |
8.8.5. Environmental and Regulatory Compliance |
8.9. Technology Readiness Level Matrix |
8.10. Technology Maturity Curve |
8.11. Buying Criteria |
9. Company Profiles |
9.1. Arcadia Biosciences |
9.1.1. Company Overview |
9.1.2. Company Financials |
9.1.3. Product/Service Portfolio |
9.1.4. Recent Developments |
9.1.5. IMR Analysis |
*Similar information will be provided for other companies |
9.2. Bayer AG |
9.3. Certis USA L.L.C. |
9.4. Corteva |
9.5. Eurofins Genomics LLC |
9.6. Evogene Ltd. |
9.7. KWS SAAT SE |
9.8. Limagrain |
9.9. Mitsui & Co. (U.S.A.), Inc. |
9.10. Performance Plants Inc. |
9.11. Syngenta AG |
9.12. Thermo Fisher Scientific |
9.13. Vilmorin & Cie |
10. Appendix |
A comprehensive market research approach was employed to gather and analyze data on the Agricultural Biotechnology Market. In the process, the analysis was also done to analyze the parent market and relevant adjacencies to measure the impact of them on the Agricultural Biotechnology Market. The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.
Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.
Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the agricultural biotechnology ecosystem. The primary research objectives included:
A combination of top-down and bottom-up approaches was utilized to analyze the overall size of the Agricultural Biotechnology Market. These methods were also employed to assess the size of various subsegments within the market. The market size assessment methodology encompassed the following steps:
To ensure the accuracy and reliability of the market size, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size assessment.